With the explosion of genetic testing in the United States, our payer clients need an objective tool they can use to determine when and if a certain genetic or genomic test is necessary and medically appropriate. This is especially true in certain patients for whom multiple genetic or genomic tests might be considered. That’s why we created Hayes Genetic Testing Algorithms.
In patient populations for which multiple genetic or genomic tests might be considered, our interactive decision trees enable payers to answer the question, “At what point in the continuum of care is it appropriate to use this particular genetic test for this particular patient?”
We’ll be demonstrating where to find these algorithms in our Knowledge Center and how to use them. Contact us here or at firstname.lastname@example.org to register for one of these complimentary 30-minute demonstrations:
- Wednesday, January 9, 2013, at 1:00 pm – 1:30 pm ET
- Thursday, January 10, 2013, at 10:30 am – 11:00 am ET
- Tuesday, January 15, 2013, at 3:30 pm – 4:00 pm ET
- Wednesday, January 16, 2013, at 1:00 pm – 1:30 pm ET
Hayes GTE Program also offers coverage policy support, as well as health technology assessments and evidence reviews, for a wide variety of genetic diseases and tests, including those associated with all of the > 200 new molecular CPT codes implemented by the American Medical Association (AMA). If you have genetic testing questions, Hayes genetic test experts can give you the answers. We analyze the evidence behind these molecular tests to provide payers with the clarity and guidance they need to make informed decisions about when and how these tests should be used. With our support, payers can be assured that their business decisions about paying for and managing genetic, genomic, and proteomic tests are based on the most current information available.